The Implications of the Pandemic with Covid-19 in the Glycemic Control of People with Type 2 Diabetes

References

• Magliano DJ, Boyko EJ. IDF Diabetes Atlas, 10th edition scientific committee . IDF DIABETES ATLAS [Internet]. 10th edition. Brussels: International Diabetes Federation; 2021. ISBN-13: 978-2-930229-98-0; 2021. Avaliable from: https://www.ncbi.nlm.nih.gov/books/NBK581934/.
   Google Scholar
• Chong S, Ding D, Byun R, Comino E, Bauman A, Jalaludin B. Lifestyle changes after a diagnosis of type 2 diabetes. Diabetes Spectr. 2017;30(1):43–50. doi:10.2337/ds15-0044
   PubMedGoogle Scholar
• Ciotti M, Ciccozzi M, Terrinoni A, Jiang WC, Wang CB, Bernardini S. The COVID-19 pandemic. Crit Rev Clin Lab Sci. 2020;57(6):365–388. doi:10.1080/10408363.2020.1783198
   PubMed Web of Science ®Google Scholar
• Stein SR, Ramelli SC, Grazioli A, et al. SARS-CoV-2 infection and persistence in the human body and brain at autopsy. Nature. 2022;612(7941):758–763. doi:10.1038/s41586-022-05542-y
   PubMed Web of Science ®Google Scholar
• Popoviciu MS, Kaka N, Sethi Y, Patel N, Chopra H, Cavalu S. Type 1 diabetes mellitus and autoimmune diseases: a critical review of the association and the application of personalized medicine. J Pers Med. 2023;13(3):422. doi:10.3390/jpm13030422
   PubMed Web of Science ®Google Scholar
• Nicula M, Pacala N, Stef L, et al. In vivo experiments of natural products protection of antagonistic effects of lead on iron. Rev Chim. 2017;68:12.
   Web of Science ®Google Scholar
• Gęca T, Wojtowicz K, Guzik P, Góra T. Increased risk of COVID-19 in patients with diabetes mellitus-current challenges in pathophysiology, treatment and prevention. Int J Environ Res Public Health. 2022;19(11):6555. PMID: 35682137; PMCID: PMC9180541. doi:10.3390/ijerph19116555
   PubMed Web of Science ®Google Scholar
• Sen S, Chakraborty R, Kalita P, Pathak MP. Diabetes mellitus and COVID-19: understanding the association in light of current evidence. World J Clin Cases. 2021;9(28):8327–8339. PMID: 34754842; PMCID: PMC8554438. doi:10.12998/wjcc.v9.i28.8327
   PubMed Web of Science ®Google Scholar
• Eberle C, Stichling S. Impact of COVID-19 lockdown on glycemic control in patients with type 1 and type 2 diabetes mellitus: a systematic review. Diabetol Metab Syndr. 2021;13(1):95. doi:10.1186/s13098-021-00705-9
   PubMed Web of Science ®Google Scholar
• Patel SY, McCoy RG, Barnett ML, Shah ND, Mehrotra A. Diabetes care and glycemic control during the COVID-19 pandemic in the United States. JAMA Intern Med. 2021;181(10):1412–1414. doi:10.1001/jamainternmed.2021.3047
   PubMed Web of Science ®Google Scholar
• Young DR, Sallis JF, Baecker A, et al. Associations of physical inactivity and COVID-19 outcomes among subgroups. Am J Prev Med. 2023;64(4):492–502. doi:10.1016/j.amepre.2022.10.007
   PubMed Web of Science ®Google Scholar
• Canfield SL, Zuckerman A, Anguiano RH, et al. Navigating the wild west of medication adherence reporting in specialty pharmacy. J Manag Care Spec Pharm. 2019;25(10):1073–1077. doi:10.18553/jmcp.2019.25.10.1073
   PubMed Web of Science ®Google Scholar
• Timar R, Roman G Ghid de management al diabetului zaharat elaborat de către societatea română de diabet, nutriție și boli metabolice și federația română de diabet, nutriție și boli metabolice [diabetes management guide developed by the Romanian society of diabetes, nutrition and metabolic diseases and the Romanian federation of diabetes, nutrition and metabolic diseases]; 2020.
   Google Scholar
• American Diabetes Association. Standards of medical care in diabetes-2019. Diabetes Care. 2019;42:1.
   PubMedGoogle Scholar
• Khare J, Jindal S. Observational study on effect of lock down due to COVID 19 on HBA1c levels in patients with diabetes: experience from Central India. Primary Care Diabetes. 2022;16(6):775–779. doi:10.1016/j.pcd.2020.12.003
   PubMed Web of Science ®Google Scholar
• Xue T, Li Q, Zhang Q, et al. Blood glucose levels in elderly subjects with type 2 diabetes during COVID-19 outbreak: a retrospective study in a single center. medRxiv. 2020;3:20048579.
   Google Scholar
• Park SD, Kim SW, Moon JS, et al. on the changes in glycosylated hemoglobin level in people with type 2 diabetes mellitus. Diabet Metabol J. 2019;2020:1.
   Google Scholar
• Khader MA, Jabeen T, Namoju R. A cross sectional study reveals severe disruption in glycemic control in people with diabetes during and after lockdown in India. Diabetes Metabol Synd. 2020;14(6):1579–1584. doi:10.1016/j.dsx.2020.08.011
   PubMed Web of Science ®Google Scholar
• Rastogi A, Hiteshi P, Bhansali A. Improved glycemic control amongst people with long-standing diabetes during COVID-19 lockdown: a prospective, observational, nested cohort study. Int J Diabetes Dev Count. 2020;40(4):476–481. doi:10.1007/s13410-020-00880-x
   PubMed Web of Science ®Google Scholar
• Psoma O, Papachristoforou E, Kountouri A, et al. Effect of COVID-19-associated lockdown on the metabolic control of patients with type 2 diabetes. J Diabetes Compl. 2020;34(12):107756. doi:10.1016/j.jdiacomp.2020.107756
   PubMed Web of Science ®Google Scholar
• Biancalana E, Parolini F, Mengozzi A, Solini A. Short-term impact of COVID-19 lockdown on metabolic control of patients with well-controlled type 2 diabetes: a single-centre observational study. Acta Diabetol. 2020;58(4):431–436. doi:10.1007/s00592-020-01637-y
   PubMed Web of Science ®Google Scholar
• Bonora BM, Morieri ML, Avogaro A, Fadini GP. The toll of lockdown against COVID-19 on diabetes outpatient care: analysis from an outbreak area in Northeast Italy. Diabetes Care. 2020;44(1):e18–e21. doi:10.2337/dc20-1872
   PubMed Web of Science ®Google Scholar
• Önmez A, Gamsızkan Z, Özdemir Ş, et al. The effect of COVID-19 lockdown on glycemic control in patients with type 2 diabetes mellitus in Turkey. Diabetes Metabol Synd. 2020;14(6):1963–1966. doi:10.1016/j.dsx.2020.10.007
   PubMed Web of Science ®Google Scholar
• Hikmah K, Helda H, Killeen C. Coronavirus-related anxiety with hyperglycemia in type 2 diabetes patients. Period Epidemiol J. 2022;10(2):111–120. doi:10.20473/jbe.V10I22022.111-120
   Google Scholar
• Gherbon A, Frandes M, Timar R, Timar B. The impact of COVID-19 Lockdown on glycemic balance in Romanian patients with type 1 diabetes mellitus. Diabetes Metab Syndr Obes. 2022;Volume 15:3403–3413. doi:10.2147/DMSO.S386614
   Web of Science ®Google Scholar
• Gherbon A, Frandes M, Timar R. 637-P: the impact of the lockdown on Romanian patients with type 1 diabetes and Basedow-Graves’ disease. Diabetes. 2022;71(Supplement_1). doi:10.2337/db22-637-P
   Google Scholar
• Chen Y, Yang D, Cheng B, et al. Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication. Diabetes Care. 2020;43(7):1399–1407.
   PubMed Web of Science ®Google Scholar
• Cameron AR, Morrison VL, Levin D, et al. Anti-inflammatory effects of metformin irrespective of diabetes Status. CircRes. 2016;119(5):652–665.
   Web of Science ®Google Scholar
• Cheng X, Liu YM, Li H, et al. Metformin is associated with higher incidence of acidosis, but not mortality, in individuals with COVID-19 and Pre-existing type 2 diabetes. Cell Metab. 2020;32(4):537–547.e3. doi:10.1016/j.cmet.2020.08.013
   PubMed Web of Science ®Google Scholar
• Assaad M, Hekmat-Joo N, Hosry J, et al. Insulin use in type II diabetic patients: a predictive of mortality in covid-19 infection. Diabetol Metab Syndr. 2022;14(1):85. Erratum in: Diabetol Metab Syndr. 2022;14(1):98. doi:10.1186/s13098-022-00857-2
   PubMed Web of Science ®Google Scholar
• Dhatariya K, Corsino L, Umpierrez GE. Management of diabetes and hyperglycemia in hospitalized patients. In: Feingold KR, Anawalt B, Blackman MR, editors. Endotext. South Dartmouth (MA): MDText.com, Inc; 2000.
   Google Scholar
• Mirabella S, Gomez-Paz S, Lam E, Gonzalez-Mosquera L, Fogel J, Rubinstein S. Glucose dysregulation and its association with COVID-19 mortality and hospital length of stay. Diabetes Metab Syndr. 2022;16(3):102439. doi:10.1016/j.dsx.2022.102439
   PubMed Web of Science ®Google Scholar
• Sardu C, D’Onofrio N, Balestrieri ML, et al. Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control? Diabetes Care. 2020;43(7):1408–1415. doi:10.2337/dc20-0723
   PubMed Web of Science ®Google Scholar
• Popoviciu M-S, Păduraru L, Yahya G, Metwally K, Cavalu S. Emerging role of GLP-1 agonists in obesity: a comprehensive review of randomised controlled trials. Int J Mol Sci. 2023;24(13):10449. doi:10.3390/ijms241310449
   PubMed Web of Science ®Google Scholar
• Zhang Y, Geng X, Tan Y, Li Q, Xu C, Xu J. New understanding of the damage of SARS-CoV-2 infection outside the respiratory system. Biomed Pharmacol. 2020;127. doi:10.1016/j.biopha.2020.110195
   Web of Science ®Google Scholar
• Ghosal S, Arora B, Dutta K, Ghosh A, Sinha B, Misra A. Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: a cohort analysis. Diabetes Metabol Synd. 2020;14(5):949–952. doi:10.1016/j.dsx.2020.06.020
   PubMed Web of Science ®Google Scholar
• Ruiz-Roso MB, Knott-Torcal C, Matilla-Escalante DC, Garcimartín A, Sampedro- Nuñez MA, Dávalos A. COVID-19 lockdown and changes of the dietary pattern and physical activity habits in a cohort of patients with type 2 diabetes mellitus. Nutrients. 2020;12(8):2327. doi:10.3390/nu12082327
   PubMed Web of Science ®Google Scholar
• Banerjee M, Chakraborty S, Pal R. Diabetes self-management amid COVID-19 pandemic. Diabetes Metab Syndr Clin Res Rev. 2020;14(4):351–354. doi:10.1016/j.dsx.2020.04.013
   PubMed Web of Science ®Google Scholar
• Khunti K, Aroda VR, Aschner P, et al. The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery. Lancet Diabetes Endocrinol. 2022;10(12):890–900. PMID: 36356612; PMCID: PMC9640202. doi:10.1016/S2213-8587(22)00278-9
   PubMed Web of Science ®Google Scholar
• Chudasama YV, Gillies CL, Zaccardi F, et al. Impact of COVID-19 on routine care for chronic diseases: a global survey of views from healthcare professionals. Diabetes Metab Syndr. 2020;14(5):965–967. doi:10.1016/j.dsx.2020.06.042
   PubMed Web of Science ®Google Scholar
• Bullen C, McCormack J, Calder A, et al. The impact of COVID-19 on the care of people living with noncommunicable diseases in low- and middle-income countries: an online survey of physicians and pharmacists in nine countries. Prim Health Care Res Dev. 2021;22:e30.
   PubMed Web of Science ®Google Scholar
• Kilvert A, Wilmot EG, Davies M, Fox C. Virtual consultations: are we missing anything? Pract Diabetes. 2020;37(4):143–146. doi:10.1002/pdi.2288
   Web of Science ®Google Scholar
• Kilvert A, Fox C, Calladine L. What do people with diabetes really think about remote consultations. Pract Diabetes. 2020;38(4):51–56. doi:10.1002/pdi.2353
   Web of Science ®Google Scholar